Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy
Related Experiment Video
Updated: Apr 21, 2026

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Kai-Chun Yang1, Xiucui Ma1, Haiyan Liu1
1From the Division of Cardiology and Center for Cardiovascular Research, Department of Internal Medicine (K.-C.Y., X.M., H.L., J.M., P.M.B., D.L.M., A.D.), Department of Cell Biology and Physiology (D.L.M., A.D.), Washington University School of Medicine, St. Louis, MO; and Department of Medicine, John Cochran VA Medical Center, St. Louis, MO (X.M., H.L., A.D.).
Background:
Tumor necrosis factor (TNF) signaling protects against ischemia/reperfusion-induced cardiomyocyte death, in vitro, ex vivo, and in vivo. TNF-receptor-associated factor 2 (TRAF2), an E3 ubiquitin ligase, coordinates cytoprotective signaling downstream of both TNF receptors, via unclear mechanisms. Noting that TRAF2 is recruited to mitochondria, and that autophagic removal of ubiquitin-tagged damaged mitochondria is cytoprotective, we tested the hypothesis that TRAF2 mediates mitochondrial autophagy.
Methods And Results:
TRAF2 localizes to the mitochondria in neonatal rat cardiac myocytes, and TNF treatment transcriptionally upregulates TRAF2 abundance in the mitochondrial subfraction. TRAF2 colocalizes with ubiquitin, p62 adaptor protein, and mitochondria within LC3-bound autophagosomes; and exogenous TRAF2 enhances autophagic removal of mitochondria. TRAF2 knockdown with adenoviral shRNA transduction induces accumulation of depolarized mitochondria in resting neonatal rat cardiac myocytes, as well as in those treated with TNF or uncoupling agent carbonyl cyanide m-chlorophenyl hydrazone, suggesting an essential role for TRAF2 in homeostatic and stress-induced mitochondrial autophagy. TRAF2 also colocalizes and interacts with PARKIN, a previously described E3 ubiquitin ligase and mitophagy effector, on depolarized mitochondria in neonatal rat cardiac myocytes. Exogenous expression of TRAF2, but not its E3 ligase-deficient mutants, is sufficient to partially restore mitophagy in the setting of PARKIN knockdown, suggesting redundancy in their ubiquitin ligase roles. TRAF2 abundance increases in the mitochondrial subfraction of ischemia/reperfusion-modeled hearts; and exogenous TRAF2, but not its E3 ligase-deficient mutants, reduces depolarized mitochondria and rescues cell death in neonatal rat cardiac myocytes subjected to hypoxia/reoxygenation.
Conclusions:
Taken together, these data indicate an essential role for TRAF2 in concert with PARKIN as a mitophagy effector, which contributes to TRAF2-induced cytoprotective signaling.
Insights
Tumor necrosis factor-associated factor 2 (TRAF2) mediates mitochondrial autophagy, protecting heart cells from death. TRAF2 works with PARKIN to remove damaged mitochondria, crucial for cell survival during stress.
Area of Science:
- Cardiovascular Biology
- Cellular Stress Response
- Mitochondrial Dynamics
Background:
- Tumor necrosis factor (TNF) signaling protects cardiomyocytes from death during ischemia/reperfusion injury.
- TNF-receptor-associated factor 2 (TRAF2) coordinates cytoprotective signaling downstream of TNF receptors through incompletely understood mechanisms.
- TRAF2's mitochondrial localization and the cytoprotective role of autophagic removal of damaged mitochondria prompted investigation into TRAF2's role in mitochondrial autophagy (mitophagy).
Purpose of the Study:
- To test the hypothesis that TRAF2 mediates mitochondrial autophagy.
- To elucidate the role of TRAF2 in cardiomyocyte protection against stress-induced death.
Main Methods:
- Investigated TRAF2 localization and abundance in mitochondria of neonatal rat cardiac myocytes.
- Utilized adenoviral shRNA to knock down TRAF2 and assessed mitochondrial health and autophagy.
- Examined TRAF2 interaction with PARKIN on depolarized mitochondria.
- Assessed the impact of exogenous TRAF2 expression on mitophagy in PARKIN knockdown models.
- Evaluated TRAF2's role in a rat model of cardiac ischemia/reperfusion injury.
Main Results:
- TRAF2 localizes to mitochondria and its abundance increases with TNF treatment.
- TRAF2 is found within autophagosomes with mitochondria and ubiquitin, and its presence enhances mitochondrial autophagy.
- TRAF2 knockdown leads to accumulation of damaged mitochondria, indicating its essential role in mitochondrial quality control.
- TRAF2 interacts with PARKIN on depolarized mitochondria, and TRAF2 can compensate for PARKIN loss in mitophagy.
- TRAF2 abundance increases in hearts subjected to ischemia/reperfusion.
- Exogenous TRAF2 protects against hypoxia/reoxygenation-induced cell death by reducing mitochondrial damage.
Conclusions:
- TRAF2 plays an essential role in mitophagy as a key effector, acting in concert with PARKIN.
- TRAF2-mediated mitophagy contributes significantly to TRAF2's cytoprotective signaling pathways.
- These findings highlight TRAF2 as a critical component in maintaining mitochondrial homeostasis and preventing cardiac cell death.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

